A pharmaceutical study on different approaches for itopride hydrochloride sustainment: In-vitro and in-vivo evaluation

被引:0
|
作者
机构
[1] Yehia, Soad A.
[2] El Shafeey, Ahmed H.
[3] El Meshad, Aliaa
[4] Al-Bialey, Hamoud A.
来源
Yehia, S. A. | 1600年 / Journal of Chemical and Pharmaceutical Research, 3/668 Malviya Nagar, Jaipur, Rajasthan, India卷 / 04期
关键词
Drug products - Drug dosage - Controlled drug delivery - Biochemistry - Granulation - Targeted drug delivery - Blending - Cellulose - Plastic coatings;
D O I
暂无
中图分类号
学科分类号
摘要
Recent trends indicate that dosage form drug delivery systems are especially suitable for achieving sustained or delayed release oral formulations with low risk of dose dumping, flexibility of blending to attain different release patterns as well as reproducibility. One of the approaches toward this goal was to develop and formulate extended release matrix oral tablets of itopride hydrochloride (ITO) as a highly water soluble drug and to increase its gastric retention time. Matrix tablets of (ITO) were developed using different methods such as: (wetting granulation, direct compression, and coating compression), by using different types of polymers (hydroxypropyl methyl cellulose (HPMC) K15M, hydroxypropyl cellulose (HPC) low viscosity, Eudragit&reg RL100, and Carnauba wax). The prepared tablets were evaluated according to various physicochemical characteristics such as: weight and thickness variation, drug content, hardness, friability, and in vitro drug release. Tablet weight variation ranged from 395 ± 0.34 to 409 ± 1.78 mg, thickness ranged from 3.16 ± 1.37 to 3.74 mm, drug content ranged from 94.5 ± 1.01% to 106.2 ± 0.08%, friability ranged from 0.04 ± 0.69 to 0.84 ± 0.45, and hardness ranged from 5.25 ± 0.25 to 8.80 ± 0.4 Kg/cm2. Results indicated that drug release depended upon method of preparation and polymer type. Furthermore, in vivo testing of the optimum sustained release tablet formulation (F23) using coating compression by HPMC as coat was performed in human subjects, and determined and compared to that of a commercial oral tablet (Ganaton&reg) as a reference formulation. The obtained the maximum plasma concentration (Cmax) and the area under the curve from zero to infinity (AUC (0-∞) values were higher following formulated tablet administration than after Ganaton&reg administration. The percentage relative bioavailability of ITO from the selected formula in human volunteers was found to be 243% compared to Ganaton&reg.
引用
收藏
相关论文
共 50 条
  • [21] IN-VITRO AND IN-VIVO EVALUATION OF POTENTIAL ALUMINUM CHELATORS
    GRAFF, L
    MULLER, G
    BURNEL, D
    VETERINARY AND HUMAN TOXICOLOGY, 1995, 37 (05) : 455 - 461
  • [22] Utilization of propranolol hydrochloride mucoadhesive invasomes as a locally acting contraceptive: in-vitro, ex-vivo, and in-vivo evaluation
    Teaima, Mahmoud H.
    Eltabeeb, Moaz A.
    El-Nabarawi, Mohamed A.
    Abdellatif, Menna M.
    DRUG DELIVERY, 2022, 29 (01) : 2549 - 2560
  • [23] In-vitro and in-vivo evaluation of skin barrier creams
    Cabassut, L.
    Mestres, J. P.
    Vian, L.
    Marti-Mestres, G.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (06) : 792 - 792
  • [24] EVALUATION OF THE MUTAGENICITY OF MEDROXYPROGESTERONE ACETATE IN-VITRO AND IN-VIVO
    HERZOG, R
    LEUSCHNER, J
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1995, 45-1 (03): : 311 - 314
  • [25] IN-VITRO AND IN-VIVO EVALUATION OF NIOSOMES CONTAINING CELECOXIB
    El-Ridy, M. S.
    Abd ElRahman, A. A.
    Awad, G. M.
    Khalil, R. M.
    Younis, M. M.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2014, 5 (11): : 4677 - 4688
  • [26] In-vitro and in-vivo evaluation of austocystin D liposomes
    Li, Shuo
    Hu, Jie
    Zhang, Linan
    Zhang, Li
    Sun, Yongjun
    Xie, Yinghua
    Wu, Shaomei
    Liu, Lei
    Gao, Zibin
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2013, 65 (03) : 355 - 362
  • [27] Suppressive activity of fexofenadine hydrochloride on nitric oxide production in-vitro and in-vivo
    Asano, Kazuhito
    Kanai, Ken-ichi
    Furuta, Atsuko
    Furuya, Ayako
    Suzaki, Harumi
    Hisamitsu, Tadashi
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 (10) : 1389 - 1395
  • [28] FROM IN-VITRO TO IN-VIVO
    FANTIN, B
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (05): : 757 - 758
  • [29] Synergistic anticancer efficacy of Bendamustine Hydrochloride loaded bioactive Hydroxyapatite nanoparticles: In-vitro, ex-vivo and in-vivo evaluation
    Thomas, Shindu C.
    Sharma, Harshita
    Rawat, Purnima
    Verma, Anita K.
    Leekha, Ankita
    Kumar, Vijay
    Tyagi, Aakriti
    Gurjar, Bahadur S.
    Iqbal, Zeenat
    Talegaonkar, Sushama
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2016, 146 : 852 - 860
  • [30] Novel pH responsive supramolecular hydrogels of chitosan hydrochloride and polyoxometalate: In-vitro, in-vivo and preliminary safety evaluation
    Azizullah
    Nisar-ur-Rehman
    Haider, Ali
    Kortz, Ulrich
    Afridi, Saifullah
    Sohail, Muhammad
    Joshi, Sachin A.
    Iqbal, Jamshed
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 533 (01) : 125 - 137